ASX - By Stock
|
LDX |
Re:
WHO IS PREVENTING LDX FROM RISING UP???
|
|
Kerebrad
|
23 |
2.6K |
0 |
08:00 |
08:00 |
ASX - By Stock
|
23
|
2.6K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
WHO IS PREVENTING LDX FROM RISING UP???
|
|
Kerebrad
|
23 |
2.6K |
2 |
07:28 |
07:28 |
ASX - By Stock
|
23
|
2.6K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
WHO IS PREVENTING LDX FROM RISING UP???
|
|
Kerebrad
|
23 |
2.6K |
0 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
23
|
2.6K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Change in substantial holding from RYD
|
|
Kerebrad
|
17 |
2.0K |
3 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
17
|
2.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kerebrad
|
18K |
7.0M |
1 |
18/09/24 |
18/09/24 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kerebrad
|
18K |
7.0M |
1 |
18/09/24 |
18/09/24 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kerebrad
|
18K |
7.0M |
14 |
18/09/24 |
18/09/24 |
ASX - By Stock
|
18K
|
7.0M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
Kerebrad
|
57 |
21K |
6 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
57
|
21K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
Kerebrad
|
57 |
21K |
1 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
57
|
21K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Thermo Fisher Scientific as US Distributor
|
|
Kerebrad
|
8 |
1.6K |
2 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
8
|
1.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Entering the PAZ - give us your predictions!
|
|
Kerebrad
|
144 |
47K |
10 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
144
|
47K
|
10
|
|
ASX - By Stock
|
LDX |
Re:
LDX Discussion
|
|
Kerebrad
|
398 |
59K |
1 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
398
|
59K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
NdPR price
|
|
Kerebrad
|
2.6K |
1.1M |
7 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
2.6K
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Kerebrad
|
375 |
168K |
1 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
375
|
168K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Kerebrad
|
11K |
5.5M |
5 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
11K
|
5.5M
|
5
|
|
ASX - By Stock
|
LYC |
Re:
NdPR price
|
|
Kerebrad
|
2.6K |
1.1M |
2 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
2.6K
|
1.1M
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Interesting
|
|
Kerebrad
|
476 |
178K |
6 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
476
|
178K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
10K |
3.4M |
2 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
10K
|
3.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
10K |
3.4M |
8 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
10K
|
3.4M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
10K |
3.4M |
4 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
10K
|
3.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
10K |
3.4M |
9 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
10K
|
3.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB CC Transcript 29 Aug 24
|
|
Kerebrad
|
62 |
26K |
4 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
62
|
26K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB CC Transcript 29 Aug 24
|
|
Kerebrad
|
62 |
26K |
1 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
62
|
26K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB CC Transcript 29 Aug 24
|
|
Kerebrad
|
62 |
26K |
9 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
62
|
26K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Kerebrad
|
197 |
65K |
2 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
197
|
65K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Kerebrad
|
197 |
65K |
4 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
197
|
65K
|
4
|
|
Charts
|
MSB |
Re:
chart
|
|
Kerebrad
|
166 |
81K |
4 |
30/08/24 |
30/08/24 |
Charts
|
166
|
81K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Kerebrad
|
1.8K |
803K |
8 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
1.8K
|
803K
|
8
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Kerebrad
|
1.8K |
803K |
5 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
1.8K
|
803K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Kerebrad
|
197 |
65K |
4 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
197
|
65K
|
4
|
|
ASX - By Stock
|
LYC |
Re:
NdPR price
|
|
Kerebrad
|
2.6K |
1.1M |
10 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
2.6K
|
1.1M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Kerebrad
|
197 |
65K |
12 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
197
|
65K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Kerebrad
|
197 |
65K |
28 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
197
|
65K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
Kerebrad
|
13 |
6K |
5 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
13
|
6K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Class Action Resolution
|
|
Kerebrad
|
304 |
93K |
9 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
304
|
93K
|
9
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC Lynas Rare Earths' annual profit slumps around 73%
|
|
Kerebrad
|
46 |
14K |
4 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
46
|
14K
|
4
|
|
ASX - By Stock
|
LYC |
Re:
Stock price
|
|
Kerebrad
|
522 |
194K |
3 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
522
|
194K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: H1 2024 financial results
|
|
Kerebrad
|
13 |
7.9K |
68 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
13
|
7.9K
|
68
|
|
ASX - By Stock
|
LYC |
Re:
Stock price
|
|
Kerebrad
|
522 |
194K |
8 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
522
|
194K
|
8
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos and BDI Progress New Point of Care Test
|
|
Kerebrad
|
10 |
2.2K |
7 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
10
|
2.2K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
10K |
3.4M |
22 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
10K
|
3.4M
|
22
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives Research & Development Tax Rebate
|
|
Kerebrad
|
27 |
4.2K |
0 |
25/08/24 |
25/08/24 |
ASX - By Stock
|
27
|
4.2K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
Kerebrad
|
80 |
34K |
7 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
80
|
34K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
Kerebrad
|
80 |
34K |
24 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
80
|
34K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
Kerebrad
|
80 |
34K |
28 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
80
|
34K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
Kerebrad
|
87 |
45K |
8 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
87
|
45K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kerebrad
|
18K |
7.0M |
2 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
18K
|
7.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kerebrad
|
18K |
7.0M |
3 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
18K
|
7.0M
|
3
|
|
ASX - By Stock
|
LYC |
Re:
Interesting
|
|
Kerebrad
|
476 |
178K |
7 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
476
|
178K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
Kerebrad
|
259 |
147K |
15 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
259
|
147K
|
15
|
|